RECRUITINGN/A

Postoperative Outcomes in Patients With Hepato-biliary-pancreatic Cancer According to inBody Test

postoperative outcomes were evaluated by using inBody test

Sponsor

Kochi University

Enrollment

1,000 participants

Sites

1 locations

Start Date

January 2019

Completion

January 2025

Cancerinbody

Enrollment & Timeline

Recruiting

Target enrollment (estimated)

Target N

1,000

participants

Sites

locations

Duration

11.0 years

total trial span

Rate

pts/month needed

Jan 2019Month 89 of 132Jan 2025

67% of trial timeline elapsed43 months to primary endpoint

At 1 sites, each site needs to enroll approximately 8.0 patients/month to hit the enrollment target on schedule.

Enrollment target is estimated. ClinicalTrials.gov does not provide real-time enrollment progress.

View on ClinicalTrials.gov

Ask AI

Primary Outcomes

long-term outcomes

5year

overall survival rate

Ask AI

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

Preoperative percent body fat in bioelectrical impedance analysis predicts pancreatic fistula after pancreaticoduodenectomy.

Kimura Jiro, Sui Kenta, Tabuchi Motoyasu et al.Langenbeck's archives of surgery2023

DOI PubMed

PubMed/NCBI (daily updates) FDA FAERS (quarterly updates) WHO ICTRP (weekly updates)

Ask AI

Fetching protocol from ClinicalTrials.gov…

RECRUITINGN/A

Postoperative Outcomes in Patients With Hepato-biliary-pancreatic Cancer According to inBody Test

postoperative outcomes were evaluated by using inBody test

Sponsor

Kochi University

Enrollment

1,000 participants

Sites

1 locations

Start Date

January 2019

Completion

January 2025

Cancerinbody

Enrollment & Timeline

Recruiting

Target enrollment (estimated)

Target N

1,000

participants

Sites

locations

Duration

11.0 years

total trial span

Rate

pts/month needed

Jan 2019Month 89 of 132Jan 2025

67% of trial timeline elapsed43 months to primary endpoint

At 1 sites, each site needs to enroll approximately 8.0 patients/month to hit the enrollment target on schedule.

Enrollment target is estimated. ClinicalTrials.gov does not provide real-time enrollment progress.

View on ClinicalTrials.gov

Ask AI

Primary Outcomes

long-term outcomes

5year

overall survival rate

Ask AI

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

Preoperative percent body fat in bioelectrical impedance analysis predicts pancreatic fistula after pancreaticoduodenectomy.

Kimura Jiro, Sui Kenta, Tabuchi Motoyasu et al.Langenbeck's archives of surgery2023

DOI PubMed

PubMed/NCBI (daily updates) FDA FAERS (quarterly updates) WHO ICTRP (weekly updates)

Ask AI

Eligibility

Min Age

18 Years

Max Age

90 Years

Sex

all

Healthy Volunteers

View full criteria

Inclusion Criteria:

* surgically treated patients

Exclusion Criteria:

* a body weight loss of \>10% during the 6 months before surgery; the presence of distant metastases; or seriously impaired function of vital organs because of respiratory, renal, or heart disease

Postoperative Outcomes in Patients With Hepato-biliary-pancreatic Cancer According to inBody Test

Enrollment & Timeline

Primary Outcomes

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

Postoperative Outcomes in Patients With Hepato-biliary-pancreatic Cancer According to inBody Test

Enrollment & Timeline

Primary Outcomes

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

Eligibility

Trial Sites (1)